US Patent Issued to Pharmako Biotechnologies on Jan. 28 for "Liquid dispersible curcuminoid compositions and methods of improving cognitive function" (Australian Inventor)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,067, issued on Jan. 28, was assigned to Pharmako Biotechnologies Pty Ltd. (New South Wales, Australia).

"Liquid dispersible curcuminoid compositions and methods of improving cognitive function" was invented by George Kokkinis (Frenchs Forrest, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "Brain-derived neurotrophic factor (BDNF) is known to be related to normal neuronal function and energy homeostasis, and increased levels of serum BDNF are associated with improved cognitive function, including learning and memory. The present invention relates generally to a method of preparing compositions for increasing the serum levels of brain-derive...